Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Lymphoma 112Lymphoma, Large B-Cell, Diffuse 77Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Leukemia 47Burkitt Lymphoma 45Lymphoma, Non-Hodgkin 35Lymphoma, Mantle-Cell 28Lymphoma, Follicular 27Hodgkin Disease 22Neuroblastoma 19Central Nervous System Neoplasms 19Sarcoma 18Lymphoma, B-Cell 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Large-Cell, Immunoblastic 12Lymphoma, T-Cell, Peripheral 11Lymphoma, Large-Cell, Anaplastic 11Neoplasms 10Multiple Myeloma 10Dendritic Cell Sarcoma, Interdigitating 10Sarcoma, Ewing 9Rhabdomyosarcoma 9Retinoblastoma 9Medulloblastoma 9Lymphoma, B-Cell, Marginal Zone 8Leukemia, Biphenotypic, Acute 8Recurrence 7Neuroectodermal Tumors, Primitive, Peripheral 7Lymphoma, T-Cell 7HIV Infections 7

Interventions

Cyclophosphamide 5venetoclax 3tagraxofusp 3fludarabine phosphate 3Whole-Body Irradiation 3Thiotepa 3Mycophenolic Acid 3Methotrexate 3merphos 2Tacrolimus 2Cyclosporins 2Cyclosporine 2prednylidene 1lorvotuzumab mertansine 1fludarabine 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1azathiopurine 1auricularum 1X-Rays 1Vincristine 1Specimen Handling 1Sirolimus 1Rituximab 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Blastic Plasmacytoid Dendritic Cell Neoplasm × Vincristine × Clear all
NCT04216524 2026-04-14

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

M.D. Anderson Cancer Center

Phase 2 Recruiting
40 enrolled
Myeloid

Blastic Plasmacytoid Dendritic Cell Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡